• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MEM
Click for more information
0.00% 0.5¢

MEMPHASYS LIMITED. - Announcements

Market Cap $13.00M  ! watchlist Created with Sketch. Add to my watchlist

Memphasys Limited is an Australia-based reproductive biotechnology company. The Company... Memphasys Limited is an Australia-based reproductive biotechnology company. The Company is engaged in developing medical devices, diagnostics, and media with application to assisted reproductive technology (ART) in humans and animals. The Company's product pipeline includes Felix, RoXsta, and AI-Port. Its advanced product, the Felix System, is a patented automated device for quickly and gently separating sperm from a semen sample for use in ART procedures. The Felix device consists of two main components: a console, which supplies electrical power, and a sterile disposable cartridge for sperm isolation and selection. RoXsta is an in-vitro diagnostic device that assesses semen and other bodily fluids for oxidative stress load. RoXsta also has an application as part of a suite of products that can support the animal industry. AI-Port has been developed for the purpose of maintaining the viability of livestock semen for up to seven days at a temperature range of 22 - 25 degrees Celsius.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
MEMNuSep Singapore PrIME Fundraising and Appendix 3BPRICE SENSITIVE01/05/13
MEMReinstatement to Official QuotationPRICE SENSITIVE01/03/13
MEMNuSep Half Year Report & AccountsPRICE SENSITIVE01/03/13
AEJ +Suspension from Official QuotationPRICE SENSITIVE01/03/13
MEMNuSep divests non Core ProteoIQ softwarePRICE SENSITIVE24/01/13
MEMPrIME completes first three trial production runs of AlbuminPRICE SENSITIVE08/01/13
MEMUpdate on PrIME Spin Out ResolutionPRICE SENSITIVE04/12/12
MEMBoard UpdatePRICE SENSITIVE30/11/12
MEMNuSep achieves TGA accreditation for DiagnosticsPRICE SENSITIVE12/11/12
MEMNuSep Makes a 15% PlacementPRICE SENSITIVE30/10/12
MEMSpin Out of PrIME BiologicsPRICE SENSITIVE15/10/12
MEMCritical Milestone with Installation of PrIME unit in SingapPRICE SENSITIVE03/10/12
MEMNuSep Working Capital Advance and update on DCS DebtPRICE SENSITIVE27/09/12
MEMNuSep announces 30 June 2012 Full Year ResultsPRICE SENSITIVE30/08/12
MEMUpdate on PrIME Developments and impact on 30.06.12 resultsPRICE SENSITIVE28/08/12
MEMNuSep Restructures Board and Company to Focus on PrIME technPRICE SENSITIVE16/08/12
MEMNSP receives S$6M investment in Singapore Plasma BusinesssPRICE SENSITIVE14/08/12
MEMNuSep Settles NxGen Legal CasePRICE SENSITIVE14/06/12
MEMNuSep Expands Gels Distribution with BioExpress in the USPRICE SENSITIVE05/06/12
MEMNuSep Lodges Two Patent ApplicationsPRICE SENSITIVE29/05/12
MEMHOA to establish Singapore Plasma Fractionation FacilityPRICE SENSITIVE26/04/12
MEMUpdate on Payment of $1.8M on Exercise of Share OptionsPRICE SENSITIVE02/04/12
MEMNuSep Working Capital AdvancePRICE SENSITIVE30/03/12
MEMNuSep signs Distribution Agreement with In Vitro TechnologiePRICE SENSITIVE06/03/12
MEMCorrection to Appendix 4DPRICE SENSITIVE01/03/12
MEMNuSep announces Half Year ProfitPRICE SENSITIVE29/02/12
MEMExercise of 12m 15cent Share OptionsPRICE SENSITIVE25/11/11
MEMConversion of $225,000 of Convertible NotesPRICE SENSITIVE17/10/11
MEMNuSep Letter from the ChairmanPRICE SENSITIVE10/10/11
MEMPreliminary Final ReportPRICE SENSITIVE31/08/11
MEMNuSep 15c Bonus Share OptionsPRICE SENSITIVE12/08/11
MEMNuSep Signs Letter of Intent with United LaboratoriesPRICE SENSITIVE27/07/11
MEMSingapore Government Provides Financial and Economic SuppPRICE SENSITIVE25/07/11
MEMNuSep SPO ProspectusPRICE SENSITIVE06/07/11
MEMNuSep signs 3 Year Gels Distribution AgreementPRICE SENSITIVE28/06/11
MEM$1.5m Underwriting of the SPO and Investor MeetingsPRICE SENSITIVE22/06/11
MEMPart Settlement of US Intellectual Property Legal CasePRICE SENSITIVE20/06/11
MEMNuSep Announces a Bonus Issue and SPP UpdatePRICE SENSITIVE20/06/11
MEMNuSep Announces a SPPPRICE SENSITIVE14/06/11
MEMNuSep Market UpdatePRICE SENSITIVE27/05/11
MEMNuSep Launches New GelsPRICE SENSITIVE08/04/11
MEMNuSep Half Year Results Dec 2010PRICE SENSITIVE25/02/11
MEMProspectus for the Dec 2010 SPP Bonus Share OptionsPRICE SENSITIVE04/02/11
MEMNuSep Announces Share Purchase PlanPRICE SENSITIVE09/12/10
MEMNSP AGM PresentationPRICE SENSITIVE29/11/10
MEMNuSep completes $1.9m Share PlacementPRICE SENSITIVE29/11/10
MEMTrading HaltPRICE SENSITIVE25/11/10
MEMNuSep enters $1 billion Asian blood plasma marketPRICE SENSITIVE24/11/10
MEMNuSep is Awarded Government GrantPRICE SENSITIVE04/11/10
MEMNuSep Sues Expedeon for Patent InfringementPRICE SENSITIVE04/11/10
MEMNuSep pays Final Debt Instalment and is now Debt FreePRICE SENSITIVE18/10/10
MEMNuSep announces Maiden $3.29m Net ProfitPRICE SENSITIVE17/08/10
MEMReplacement Rights Issue ProspectusPRICE SENSITIVE06/05/10
MEMNon-Renounceable Issue ProspectusPRICE SENSITIVE16/04/10
MEMInvestor Presentations and Timetable for Rights IssuePRICE SENSITIVE26/03/10
MEMSpermSep Patent Application LodgedPRICE SENSITIVE23/03/10
MEMNuSep to Fund BioInquire Acquisition and IVF SpermSepPRICE SENSITIVE17/03/10
MEMSpermSep European Patent GrantedPRICE SENSITIVE08/03/10
MEMNuSep Completes Acquisition and Upgrades Profit ForecastPRICE SENSITIVE18/02/10
MEMNuSep Announces Maiden Operational ProfitPRICE SENSITIVE16/02/10
MEMIncreases Profit Forecast to $1m after it Acquires BioInquirPRICE SENSITIVE09/12/09
MEMTrading HaltPRICE SENSITIVE07/12/09
MEMNuSep On Track after 1st QuarterPRICE SENSITIVE23/11/09
MEMRecovery of $636,000 from NxGenPRICE SENSITIVE17/11/09
MEMSpermSep Australian Patent GrantedPRICE SENSITIVE09/11/09
MEMNuSep raises $3.75m following conversion of Director LoansPRICE SENSITIVE14/09/09
MEMNuSep Shareholder Newsletter Sept 2009PRICE SENSITIVE01/09/09
MEMNuSep Preliminary Final Report 30 June 2009PRICE SENSITIVE28/08/09
MEM30 June 2010 Forecast $500,000 Net ProfitPRICE SENSITIVE18/08/09
MEMSPO Prospectus and Market UpdatePRICE SENSITIVE10/08/09
MEMNuSep Lodges $2m SPO ProspectusPRICE SENSITIVE06/08/09
MEMReinstatement to Official QuotationPRICE SENSITIVE09/07/09
MEMSuspension from Official QuotationPRICE SENSITIVE13/03/09
MEMTrading HaltPRICE SENSITIVE13/03/09
MEMProspectus To Acquire NxGenPRICE SENSITIVE11/03/09
MEMNuSep Half Year Report and AccountsPRICE SENSITIVE27/02/09
MEMSigns Binding Agreement to Acquire NxGenPRICE SENSITIVE01/12/08
MEMNuSep Singapore PrIME Fundraising and Appendix 3B
01/05/13PRICE SENSITIVE
MEMReinstatement to Official Quotation
01/03/13PRICE SENSITIVE
MEMNuSep Half Year Report & Accounts
01/03/13PRICE SENSITIVE
AEJ +Suspension from Official Quotation
01/03/13PRICE SENSITIVE
MEMNuSep divests non Core ProteoIQ software
24/01/13PRICE SENSITIVE
MEMPrIME completes first three trial production runs of Albumin
08/01/13PRICE SENSITIVE
MEMUpdate on PrIME Spin Out Resolution
04/12/12PRICE SENSITIVE
MEMBoard Update
30/11/12PRICE SENSITIVE
MEMNuSep achieves TGA accreditation for Diagnostics
12/11/12PRICE SENSITIVE
MEMNuSep Makes a 15% Placement
30/10/12PRICE SENSITIVE
MEMSpin Out of PrIME Biologics
15/10/12PRICE SENSITIVE
MEMCritical Milestone with Installation of PrIME unit in Singap
03/10/12PRICE SENSITIVE
MEMNuSep Working Capital Advance and update on DCS Debt
27/09/12PRICE SENSITIVE
MEMNuSep announces 30 June 2012 Full Year Results
30/08/12PRICE SENSITIVE
MEMUpdate on PrIME Developments and impact on 30.06.12 results
28/08/12PRICE SENSITIVE
MEMNuSep Restructures Board and Company to Focus on PrIME techn
16/08/12PRICE SENSITIVE
MEMNSP receives S$6M investment in Singapore Plasma Businesss
14/08/12PRICE SENSITIVE
MEMNuSep Settles NxGen Legal Case
14/06/12PRICE SENSITIVE
MEMNuSep Expands Gels Distribution with BioExpress in the US
05/06/12PRICE SENSITIVE
MEMNuSep Lodges Two Patent Applications
29/05/12PRICE SENSITIVE
MEMHOA to establish Singapore Plasma Fractionation Facility
26/04/12PRICE SENSITIVE
MEMUpdate on Payment of $1.8M on Exercise of Share Options
02/04/12PRICE SENSITIVE
MEMNuSep Working Capital Advance
30/03/12PRICE SENSITIVE
MEMNuSep signs Distribution Agreement with In Vitro Technologie
06/03/12PRICE SENSITIVE
MEMCorrection to Appendix 4D
01/03/12PRICE SENSITIVE
MEMNuSep announces Half Year Profit
29/02/12PRICE SENSITIVE
MEMExercise of 12m 15cent Share Options
25/11/11PRICE SENSITIVE
MEMConversion of $225,000 of Convertible Notes
17/10/11PRICE SENSITIVE
MEMNuSep Letter from the Chairman
10/10/11PRICE SENSITIVE
MEMPreliminary Final Report
31/08/11PRICE SENSITIVE
MEMNuSep 15c Bonus Share Options
12/08/11PRICE SENSITIVE
MEMNuSep Signs Letter of Intent with United Laboratories
27/07/11PRICE SENSITIVE
MEMSingapore Government Provides Financial and Economic Supp
25/07/11PRICE SENSITIVE
MEMNuSep SPO Prospectus
06/07/11PRICE SENSITIVE
MEMNuSep signs 3 Year Gels Distribution Agreement
28/06/11PRICE SENSITIVE
MEM$1.5m Underwriting of the SPO and Investor Meetings
22/06/11PRICE SENSITIVE
MEMPart Settlement of US Intellectual Property Legal Case
20/06/11PRICE SENSITIVE
MEMNuSep Announces a Bonus Issue and SPP Update
20/06/11PRICE SENSITIVE
MEMNuSep Announces a SPP
14/06/11PRICE SENSITIVE
MEMNuSep Market Update
27/05/11PRICE SENSITIVE
MEMNuSep Launches New Gels
08/04/11PRICE SENSITIVE
MEMNuSep Half Year Results Dec 2010
25/02/11PRICE SENSITIVE
MEMProspectus for the Dec 2010 SPP Bonus Share Options
04/02/11PRICE SENSITIVE
MEMNuSep Announces Share Purchase Plan
09/12/10PRICE SENSITIVE
MEMNSP AGM Presentation
29/11/10PRICE SENSITIVE
MEMNuSep completes $1.9m Share Placement
29/11/10PRICE SENSITIVE
MEMTrading Halt
25/11/10PRICE SENSITIVE
MEMNuSep enters $1 billion Asian blood plasma market
24/11/10PRICE SENSITIVE
MEMNuSep is Awarded Government Grant
04/11/10PRICE SENSITIVE
MEMNuSep Sues Expedeon for Patent Infringement
04/11/10PRICE SENSITIVE
MEMNuSep pays Final Debt Instalment and is now Debt Free
18/10/10PRICE SENSITIVE
MEMNuSep announces Maiden $3.29m Net Profit
17/08/10PRICE SENSITIVE
MEMReplacement Rights Issue Prospectus
06/05/10PRICE SENSITIVE
MEMNon-Renounceable Issue Prospectus
16/04/10PRICE SENSITIVE
MEMInvestor Presentations and Timetable for Rights Issue
26/03/10PRICE SENSITIVE
MEMSpermSep Patent Application Lodged
23/03/10PRICE SENSITIVE
MEMNuSep to Fund BioInquire Acquisition and IVF SpermSep
17/03/10PRICE SENSITIVE
MEMSpermSep European Patent Granted
08/03/10PRICE SENSITIVE
MEMNuSep Completes Acquisition and Upgrades Profit Forecast
18/02/10PRICE SENSITIVE
MEMNuSep Announces Maiden Operational Profit
16/02/10PRICE SENSITIVE
MEMIncreases Profit Forecast to $1m after it Acquires BioInquir
09/12/09PRICE SENSITIVE
MEMTrading Halt
07/12/09PRICE SENSITIVE
MEMNuSep On Track after 1st Quarter
23/11/09PRICE SENSITIVE
MEMRecovery of $636,000 from NxGen
17/11/09PRICE SENSITIVE
MEMSpermSep Australian Patent Granted
09/11/09PRICE SENSITIVE
MEMNuSep raises $3.75m following conversion of Director Loans
14/09/09PRICE SENSITIVE
MEMNuSep Shareholder Newsletter Sept 2009
01/09/09PRICE SENSITIVE
MEMNuSep Preliminary Final Report 30 June 2009
28/08/09PRICE SENSITIVE
MEM30 June 2010 Forecast $500,000 Net Profit
18/08/09PRICE SENSITIVE
MEMSPO Prospectus and Market Update
10/08/09PRICE SENSITIVE
MEMNuSep Lodges $2m SPO Prospectus
06/08/09PRICE SENSITIVE
MEMReinstatement to Official Quotation
09/07/09PRICE SENSITIVE
MEMSuspension from Official Quotation
13/03/09PRICE SENSITIVE
MEMTrading Halt
13/03/09PRICE SENSITIVE
MEMProspectus To Acquire NxGen
11/03/09PRICE SENSITIVE
MEMNuSep Half Year Report and Accounts
27/02/09PRICE SENSITIVE
MEMSigns Binding Agreement to Acquire NxGen
01/12/08PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
0.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $13.00M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
7 6639600 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 11066843 9
View Market Depth
Last trade - 10.04am 29/11/2024 (20 minute delay) ?
MEM (ASX) Chart

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
Monash tests show strong cardioprotective qualities for Algorae drug candidate Algorae Pharmaceutical Ltd has completed preclinical tests on its drug candidate for heart disease, AI-168
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.